C.H.I.P.S. HOME PAGE
PHARMACEUETICAL
COSMETIC
SUBJECT LIST
TITLE LIST
MANUAL ORDER FORM
ONLINE ORDER FORM
QUESTIONS COMMENTS

Clinical Trials for Drug Testing
from C.H.I.P.S.

Simulation for Designing Clinical Trials
A Pharmacokinetic-Pharmacodynamic Modeling Perspective
edited by Hui C. Kimko and Stephen B. Duffull

Simulation for Designing Clinical Trials discusses:

  • selecting clinical trial designs according to their probability for success
  • techniques to define distributions of virtual subjects’ characteristics
  • methods to determine the sensitivity of the trial design
  • the population relationship between dosing schedules and patient response

Contents

  1. Introduction to Simulation for Design of Clinical Trials

Models for Simulation

  1. Input-Output Models
  2. Defining Covariate Distribution Models for Clinical Trial Simulation
  3. Protocol Deviations and Execution Models
  4. Determination of Model Appropriateness

Computation in Simulation

  1. Computational Considerations in Clinical Trial Simulations

Analyses of the Simulations

  1. Analysis of Simulated Clinical Trials
  2. Sensitivity Analysis of Pharmacokinetic and Pharmacodynamic Models in Clinical Trial Simulation and Design
  3. Choice of Best Design

Perspectives on Clinical Trial Simulation

  1. Clinical Trial Simulation (CTS): A Regulatory Clinical Pharmacology Perspective
  2. Academic Perspective: Modeling and Simulation as a Teaching Tool
  3. Modeling and Simulation of Clinical Trials: An Industry Perspective
  4. History-Informed Perspectives on the Modeling and Simulation of Therapeutic Drug Actions

Applications

  1. Evaluation of Random Sparse Sampling Designs for a Population Pharmacokinetic Study: Assessment of Power and Bias Using Simulation
  2. Use of Modeling and Simulation to Optimize Dose-Finding Strategies
  3. Model-Based Integration for Clinical Trial Simulation and Design: A Phase II Case Study for Naratriptan
  4. Prediction of Hemodynamic Responses in Hypertensive and Elderly Subjects from Healthy Volunteer Data: The Example of Intravenous Nicardipine
  5. Assessment of QTc Interval Prolongation in a Phase I Study Using Monte Carlo Simulation
  6. Optimizing a Bayesian Dose-Adjustment Scheme for a Pediatric Trial: A Simulation Study

Index

click here to see books of related interest

ORDER NOW
Simulation for Designing Clinical Trials
A Pharmacokinetic-Pharmacodynamic Modeling Perspective
edited by Hui C. Kimko and Stephen B. Duffull

396 pages • $228.95 + shipping
Texas residents please add 6.75 % sales tax

copyright © 1997-2009 Culinary and Hospitality Industry Publications Services